Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
AXSM on Nasdaq
Nick Pizzie - trading volume in the past year for Axsome Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
42.2K |
$5.53M |
$131.07 |
14 Feb 2025 |
Direct |
|
|
| Performance Stock Units |
9.42K |
$1.24M |
$131.07 |
24 Feb 2025 |
Direct |
Common Stock |
|
| Restricted Stock Units |
9.42K |
$1.24M |
$131.07 |
21 Feb 2025 |
Direct |
Common Stock |
|
| Common Stock |
488 |
$64K |
$131.07 |
13 Feb 2025 |
Indirect |
|
|
| Stock Option (Right to Buy) |
0 |
$0 |
$3.50 |
14 Feb 2025 |
Direct |
Common Stock |
|
| Employee Stock Option (Right to Buy) |
9.52K |
|
|
21 Feb 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.